[CAS NO. 73725-85-6] Lidanserin
PRODUCTS SPECIFICATIONS [73725-85-6]
DESCRIPTION [73725-85-6]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 454.53 |
| Molecular Formula | C26H31FN2O4 |
| SMILES | O=C1NCC(C2=CC=C(OC)C(OCCCN3CCC(C(C4=CC=C(F)C=C4)=O)CC3)=C2)C1 |
Summary
Lidanserin (ZK-33839) acts as a 5-HT 2A and α 1 -adrenergic receptor antagonist.
IC50 & Target
|
5-HT 2A Receptor |
α1-adrenergic receptor |
In Vitro
Lidanserin is a combined 5-HT 2A and α 1 -adrenergic receptor antagonist. Lidanserin is uaed as an antihypertensive agent.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : 50 mg/mL ( 110.00 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.2001 mL | 11.0004 mL | 22.0007 mL |
| 5 mM | 0.4400 mL | 2.2001 mL | 4.4001 mL |
| 10 mM | 0.2200 mL | 1.1000 mL | 2.2001 mL |
References
Synonyms
